Finance

Lists
Why is LUNG up 3,37%?
Dive Deeper
LUNG:NASDAQ
Pulmonx Corp
1,84 $
+3,37%
(+0,060) 1D
1,84 $
0,00% (0,00)
After hours
Closed: 7 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LUNG...
Open
1,75 $
High
1,91 $
Low
1,75 $
Mkt. cap
79,02 մլն
Avg. vol.
293,86 հզր
Volume
0,00
52-wk high
2,89 $
52-wk low
1,13 $
EPS
-1,16 $
Beta
0,33
Shares outstanding
42,95 մլն
No. of employees
296
Open
1,75 $
High
1,91 $
Low
1,75 $
Mkt. cap
79,02 մլն
Avg. vol.
293,86 հզր
Volume
0,00
52-wk high
2,89 $
52-wk low
1,13 $
EPS
-1,16 $
Beta
0,33
Shares outstanding
42,95 մլն
No. of employees
296
News stories
From web sources and news partners
About Pulmonx Corp
CEO-
Employees296
Founded1995
HeadquartersՌեդվուդ Սիթի, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitepulmonx.com
Analyst ratings
Based on 4 analysts giving stock ratings to LUNG in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LUNG in the last 3 months.
Highest
Current 1,84 $
5,00 $ (+171,74%)
Average
3,50 $ (+90,22%)
Lowest
2,50 $ (+35,87%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Young CFA
Canaccord Genuity
Buy
Maintained
5,00 $
+171,7%
08/11/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
2,50 $
+35,9%
07/30/2026
Frank Takkinen
Lake Street
Buy
Reiterated
4,00 $
+117,4%
07/30/2026
Jason Bednar
Piper Sandler
Hold
Maintained
2,50 $
+35,9%
07/30/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
5,00 $
+171,7%
04/30/2026
Last report
29 հլս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,24 $ / -0,28 $
+14,29%beat
Revenue / Est. (USD)
22,76 մլն / 22,50 մլն
+1,14%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
21,50 մլն
22,60 մլն
20,59 մլն
22,76 մլն
Cost of goods sold
5,45 մլն
5,06 մլն
4,54 մլն
5,01 մլն
Cost of revenue
5,45 մլն
5,06 մլն
4,54 մլն
5,01 մլն
Research and development expenses
4,85 մլն
4,58 մլն
4,90 մլն
5,03 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25,60 մլն
22,86 մլն
24,10 մլն
21,76 մլն
Operating expense
30,44 մլն
27,44 մլն
29,00 մլն
26,80 մլն
Total operating expenses
35,90 մլն
32,50 մլն
33,54 մլն
31,81 մլն
Operating income
-14,39 մլն
-9,90 մլն
-12,96 մլն
-9,06 մլն
Other non operating income
-42,00 հզր
81,00 հզր
277,00 հզր
99,00 հզր
EBT including unusual items
-13,83 մլն
-10,24 մլն
-13,50 մլն
-9,95 մլն
EBT excluding unusual items
-13,83 մլն
-10,24 մլն
-13,50 մլն
-9,95 մլն
Income tax expense
128,00 հզր
186,00 հզր
149,00 հզր
133,00 հզր
Effective tax rate
-0,93%
-1,82%
-1,10%
-1,34%
Other operating expenses
-
-
-
-
Net income
-13,96 մլն
-10,42 մլն
-13,65 մլն
-10,08 մլն
Net profit margin
-64,91%
-46,13%
-66,33%
-44,30%
Earnings per share
-0,34
-0,25
-0,33
-0,24
Interest and investment income
611,00 հզր
453,00 հզր
350,00 հզր
329,00 հզր
Interest expense
-805,00 հզր
-770,00 հզր
-976,00 հզր
-1,22 մլն
Net interest expenses
-194,00 հզր
-317,00 հզր
-626,00 հզր
-889,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,25 մլն
-9,57 մլն
-12,84 մլն
-8,84 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps